Brian Young, M.D.

Brian Yim Young, M.D.




Internal Medicine


  • Professor of Medicine


To see if Brian Yim Young is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Lawrence J. Ellison Ambulatory Care Center

4860 Y St., Suite 0100
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Clinical Interests

Dr. Young is interested in providing excellent care to adults with kidney disease. This includes those with reduced kidney function, electrolyte imbalance, hypertension, as well as patients requiring long-term kidney replacement therapy such as dialysis. Dr. Young also helps train medical students, residents, and fellows into our future kidney doctors.




M.D., UC Los Angeles / Drew School of Medicine, Los Angeles CA 2002

B.A., Harvard University, Cambridge MA 1998

Internship: Internal Medicine, UC Los Angeles School of Medicine, Los Angeles CA 2002-2003


Internal Medicine, UC Los Angeles School of Medicine, Los Angeles CA 2002-2005


Nephrology, UC Los Angeles School of Medicine, Los Angeles CA 2005-2007

Board Certifications

American Board of Internal Medicine, 2015

American Board of Internal Medicine, Nephrology, 2017

Professional Memberships

Alpha Omega Alpha

American Society of Nephrology

National Kidney Foundation

Honors and Awards

UC Davis Department of Internal Medicine Specialty Teaching Award, 2019

Stanford Nephrology Division Teaching Attending of the Year 2012, 2014, 2015

UCLA Internal Medicine Residency Program Teaching Fellow of the Year, 2007

Charles R. Drew School of Medicine Gold Medal, 2002

Select Recent Publications

Cruz-Whitley J, Giehl N, Jen KY, Young B. Membranoproliferative Glomerulonephritis Associated with Nivolumab Therapy. Case Rep Nephrol. 2020 Feb 24;2020:2638283. doi:10.1155/2020/2638283. PMID:32257470.

Nguyen MH, Davis MR, Wittenberg R, Mchardy I, Baddley JW, Young BY, Odermatt A, Thompson GR. Posaconazole Serum Drug Levels Associated With Pseudohyperaldosteronism. Clin Infect Dis. 2020 Jun 10;70(12):2593-2598. doi: 0.1093/cid/ciz741. PMID:31403165.

Zaritsky J, Young B, Gales B, Wang HJ, Rastogi A, Westerman M, Nemeth E, Ganz T, Salusky IB. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clin J Am Soc Nephrol. 2010 Jun;5(6):1010-4. doi:10.2215/CJN.08161109. Epub 2010 Mar 18. PMID:20299375.

Young B, Zaritsky J. Hepcidin for clinicians. Clin J Am Soc Nephrol. 2009 Aug;4(8):1384-7. doi:10.2215/CJN.02190309. Epub 2009 Jun 25. PMID:19556376.

Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009 Jun;4(6):1051-6. doi:10.2215/CJN.05931108. Epub 2009 Apr 30. PMID:19406957.

Young BY, Gill J, Huang E, Takemoto SK, Anastasi B, Shah T, Bunnapradist S. Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database. Clin J Am Soc Nephrol. 2009 Apr;4(4):845-52. doi:10.2215/CJN.02250508. Epub 2009 Feb 6. PMID:19201918.